nature.com search

Loading Filters

Showing 1–34 of 34 results

Loading Filters

10 October 2016
GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies
- A Nazha
- , L Rybicki
- , D Abounader
- , B Bolwell
- , R Dean
- , A T Gerds
- , D Jagadeesh
- , B K Hamilton
- , B T Hill
- , M Kalaycio
- , H Liu
- , B Pohlman
- , R Sobecks
- , M A Sekeres
- & N S Majhail
Bone Marrow Transplantation 51 , 1642–1643

Rights & permissionsfor article GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies . Opens in a new window.
4 January 2016
Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy
- S Hong
- , J Valent
- , L Rybicki
- , D Abounader
- , B Bolwell
- , R Dean
- , A T Gerds
- , D Jagadeesh
- , B K Hamilton
- , B Hill
- , M E Kalaycio
- , B Pohlman
- , F Reu
- , C Samaras
- , R Sobecks
- , N S Majhail
- & H D Liu
Bone Marrow Transplantation 51 , 732–734

Rights & permissionsfor article Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy . Opens in a new window.
Research | 23 March 2015
Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites
- B K Hamilton
- , L Rybicki
- , M Sekeres
- , M Kalaycio
- , R Hanna
- , R Sobecks
- , R Dean
- , H Duong
- , B T Hill
- , B Bolwell
- & E Copelan
Bone Marrow Transplantation 50 , 834–839

Rights & permissionsfor article Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites . Opens in a new window.
10 June 2013
Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation
- B K Hamilton
- , B Bolwell
- , M Kalaycio
- , L Rybicki
- , R Hanna
- , R Sobecks
- , B Pohlman
- , S Andresen
- , R Dean
- , H Duong
- , B Hill
- & E Copelan
Bone Marrow Transplantation 48 , 1578–1580

Rights & permissionsfor article Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation . Opens in a new window.
Research | 11 August 2014
Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation
- M Tavadze
- , L Rybicki
- , S Mossad
- , R Avery
- , M Yurch
- , B Pohlman
- , H Duong
- , R Dean
- , B Hill
- , S Andresen
- , R Hanna
- , N Majhail
- , E Copelan
- , B Bolwell
- , M Kalaycio
- & R Sobecks
Bone Marrow Transplantation 49 , 1310–1316

Rights & permissionsfor article Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation . Opens in a new window.
28 August 2015 | Open
Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study
- B K Hamilton
- , L Rybicki
- , H Haddad
- , D Abounader
- , M Yurch
- , N S Majhail
- , R Hanna
- , R Sobecks
- , R Dean
- , H Liu
- , B Hill
- , E Copelan
- , B Bolwell
- & M Kalaycio
Blood Cancer Journal 5 , e344–e344

Rights & permissionsfor article Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study . Opens in a new window.
Research | 16 May 2011
Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation
- J Waterman
- , L Rybicki
- , B Bolwell
- , E Copelan
- , B Pohlman
- , J Sweetenham
- , R Dean
- , R Sobecks
- , S Andresen
- & M Kalaycio
Bone Marrow Transplantation 47 , 488–493

Rights & permissionsfor article Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation . Opens in a new window.
Research | 25 January 2000
High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients
- R Avery
- , B Pohlman
- , K Adal
- , B Bolwell
- , M Goldman
- , M Kalaycio
- , G Hall
- , S Andresen
- , S Mossad
- , S Schmitt
- , P Mason
- & D Longworth
Bone Marrow Transplantation 25 , 67–69

Rights & permissionsfor article High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients . Opens in a new window.
Research | 28 January 2003
Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone
- B Bolwell
- , R Sobecks
- , B Pohlman
- , S Andresen
- , K Theil
- , S Serafino
- , L Rybicki
- & M Kalaycio
Bone Marrow Transplantation 31 , 95–98

Rights & permissionsfor article Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone . Opens in a new window.
Research | 10 January 2005
Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection
- S Mossad
- , M Kalaycio
- , R Sobecks
- , B Pohlman
- , S Andresen
- , R Avery
- , L Rybicki
- , J Jarvis
- & B Bolwell
Bone Marrow Transplantation 35 , 375–381

Rights & permissionsfor article Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection . Opens in a new window.
Research | 20 December 2010
BU- vs TBI-based conditioning for adult patients with ALL
- M Kalaycio
- , B Bolwell
- , L Rybicki
- , A Absi
- , S Andresen
- , B Pohlman
- , R Dean
- , R Sobecks
- & E Copelan
Bone Marrow Transplantation 46 , 1413–1417

Rights & permissionsfor article BU- vs TBI-based conditioning for adult patients with ALL . Opens in a new window.
Research | 6 December 2004
CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens
- M Kalaycio
- , L Rybicki
- , B Pohlman
- , R Sobecks
- , E Ball
- , D Cook
- , S Andresen
- , E Kuczkowski
- & B Bolwell
Bone Marrow Transplantation 35 , 247–252

Rights & permissionsfor article CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens . Opens in a new window.
Research | 26 July 2001
Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer
- B Bolwell
- , S Andresen
- , B Pohlman
- , R Sobecks
- , M Goormastic
- , L Rybicki
- , K Bell
- & M Kalaycio
Bone Marrow Transplantation 27 , 843–846

Rights & permissionsfor article Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer . Opens in a new window.
Research | 10 January 2005
Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course
- R Avery
- , M Kalaycio
- , B Pohlman
- , R Sobecks
- , E Kuczkowski
- , S Andresen
- , S Mossad
- , J Shamp
- , J Curtis
- , J Kosar
- , K Sands
- , M Serafin
- & B Bolwell
Bone Marrow Transplantation 35 , 497–499

Rights & permissionsfor article Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course . Opens in a new window.
Research | 5 March 1998
A randomized study of multi-day infusion of autologous peripheral blood progenitor cells
- H Abdel-Razeq
- , B Pohlman
- , S Andresen
- , M Kalaycio
- , B Overmoyer
- , K Wise
- , R Dannley
- , D DeMars
- , M Goormastic
- & B Bolwell
Bone Marrow Transplantation 21 , 221–223

Rights & permissionsfor article A randomized study of multi-day infusion of autologous peripheral blood progenitor cells . Opens in a new window.
Research | 22 March 2010
Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT
- D M Mickelson
- , L Sproat
- , R Dean
- , R Sobecks
- , L Rybicki
- , M Kalaycio
- , B Pohlman
- , J Sweetenham
- , S Andresen
- , B Bolwell
- & E A Copelan
Bone Marrow Transplantation 46 , 84–89

Rights & permissionsfor article Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT . Opens in a new window.
Research | 13 August 2007
Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia
- M Kalaycio
- , L Rybicki
- , B Pohlman
- , R Dean
- , J Sweetenham
- , S Andresen
- , R Sobecks
- , M A Sekeres
- , A Advani
- , S Brown
- & B Bolwell
Bone Marrow Transplantation 40 , 753–758

Rights & permissionsfor article Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia . Opens in a new window.
Research | 22 December 2003
Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant
- B Bolwell
- , B Pohlman
- , R Sobecks
- , S Andresen
- , S Brown
- , L Rybicki
- , V Wentling
- & M Kalaycio
Bone Marrow Transplantation 33 , 419–423

Rights & permissionsfor article Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant . Opens in a new window.
Research | 10 September 1998
Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation
- B Bolwell
- , M Goormastic
- , S Andresen
- , A Koo
- , K Wise
- , B Overmoyer
- , B Pohlman
- & M Kalaycio
Bone Marrow Transplantation 22 , 547–551

Rights & permissionsfor article Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation . Opens in a new window.
Research | 24 January 2011
Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation
- S Malik
- , B Bolwell
- , L Rybicki
- , O Copelan
- , H Duong
- , R Dean
- , R Sobecks
- , M Kalaycio
- , J Sweetenham
- , B Pohlman
- , S Andresen
- , S Tench
- , A Koo
- , P Figueroa
- & E Copelan
Bone Marrow Transplantation 46 , 1519–1525

Rights & permissionsfor article Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation . Opens in a new window.
Research | 22 May 2002
Autologous hematopoietic cell transplantation for non-Hodgkin's lymphoma: 100 month follow-up
- B Bolwell
- , M Kalaycio
- , R Sobecks
- , S Andresen
- , M Mcbee
- , L Kuczkowski
- , L Rybicki
- & B Pohlman
Bone Marrow Transplantation 29 , 673–679

Rights & permissionsfor article Autologous hematopoietic cell transplantation for non-Hodgkin's lymphoma: 100 month follow-up . Opens in a new window.
Research | 2 July 2003
Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer
- J D Rizzo
- , S Williams
- , J T Wu
- , A L Pecora
- , H M Lazarus
- , B Bolwell
- , K K Fields
- , R P Gale
- , G Elfenbein
- , M M Horowitz
- & K H Antman
Bone Marrow Transplantation 32 , 151–155

Rights & permissionsfor article Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer . Opens in a new window.
20 April 2009
Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation
- A Mahindra
- , R Sobecks
- , L Rybicki
- , B Pohlman
- , R Dean
- , S Andresen
- , M Kalaycio
- , J Sweetenham
- , B Bolwell
- & E Copelan
Bone Marrow Transplantation 44 , 767–768

Rights & permissionsfor article Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation . Opens in a new window.
Research | 3 April 2000
Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group
- SN Wolff
- , J Fay
- , D Stevens
- , RH Herzig
- , B Pohlman
- , B Bolwell
- , J Lynch
- , S Ericson
- , CO Freytes
- , F LeMaistre
- , R Collins
- , L Pineiro
- , J Greer
- , R Stein
- , SA Goodman
- & S Dummer
Bone Marrow Transplantation 25 , 853–859

Rights & permissionsfor article Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group . Opens in a new window.
Research | 29 October 2012
Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study
- L W Foster
- , L McLellan
- , L Rybicki
- , J Dabney
- , E Copelan
- & B Bolwell
Bone Marrow Transplantation 48 , 671–677

Rights & permissionsfor article Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study . Opens in a new window.
Research | 4 May 2009
Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?
- C Stotler
- , B Bolwell
- , R Sobecks
- , R Dean
- , S Serafino
- , L Rybicki
- , S Andresen
- , B Pohlman
- , M Kalaycio
- & E Copelan
Bone Marrow Transplantation 45 , 49–52

Rights & permissionsfor article Are backup BM harvests worthwhile in unrelated donor allogeneic transplants? . Opens in a new window.
Research | 29 August 2011
Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS
- R M Sobecks
- , L Rybicki
- , M Yurch
- , M Kalaycio
- , R Dean
- , S Andresen
- , B Pohlman
- , H Duong
- , B Bolwell
- & E Copelan
Bone Marrow Transplantation 47 , 633–638

Rights & permissionsfor article Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS . Opens in a new window.
Research | 17 July 2000
Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation
- B Bolwell
- , J Vredenburgh
- , B Overmoyer
- , C Gilbert
- , L Chap
- , DM Menchaca
- , S Cruickshank
- & J Glaspy
Bone Marrow Transplantation 26 , 141–145

Rights & permissionsfor article Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation . Opens in a new window.
Research | 1 March 1997
Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point
- B Bolwell
- , M Goormastic
- & S Andresen
Bone Marrow Transplantation 19 , 443–448

Rights & permissionsfor article Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point . Opens in a new window.
Research | 1 February 1997
G-CSF post-autologous progenitor cell transplantation: a randomized study of 5, 10, and 16 μ g/kg/day
- B Bolwell
- , M Goormastic
- , R Dannley
- , S Andresen
- , B Overmoyer
- , Z Mendez
- , M Kalaycioglu
- , D DeMars
- , K Wise
- & B Pohlman
Bone Marrow Transplantation 19 , 215–219

Rights & permissionsfor article G-CSF post-autologous progenitor cell transplantation: a randomized study of 5, 10, and 16 μ g/kg/day . Opens in a new window.
Research | 9 August 2004
A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation
- B Bolwell
- , R Sobecks
- , B Pohlman
- , S Andresen
- , L Rybicki
- , E Kuczkowski
- & M Kalaycio
Bone Marrow Transplantation 34 , 621–625

Rights & permissionsfor article A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation . Opens in a new window.
Research | 16 March 2009
Utility of the psychosocial assessment of candidates for transplantation (PACT) scale in allogeneic BMT
- L W Foster
- , L McLellan
- , L Rybicki
- , J Dabney
- , M Visnosky
- & B Bolwell
Bone Marrow Transplantation 44 , 375–380

Rights & permissionsfor article Utility of the psychosocial assessment of candidates for transplantation (PACT) scale in allogeneic BMT . Opens in a new window.
Research | 23 July 1999
LDH elevation after autologous stem cell transplantation
- B Bolwell
- , B Pohlman
- , M Kalaycio
- , K Wise
- , M Goormastic
- & S Andresen
Bone Marrow Transplantation 24 , 53–55

Rights & permissionsfor article LDH elevation after autologous stem cell transplantation . Opens in a new window.
Research | 15 September 2008
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma
- E Copelan
- , B Pohlman
- , L Rybicki
- , M Kalaycio
- , R Sobecks
- , S Andresen
- , R Dean
- , A Koo
- , J Chan
- , J Sweetenham
- & B Bolwell
Bone Marrow Transplantation 43 , 101–105

Rights & permissionsfor article A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma . Opens in a new window.

Refine your results by…

Filters

Filter By:

GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies

Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy

Racial differences in allogeneic hematopoietic cell transplantation outcomes among African Americans and whites

Long-term follow-up of a prospective randomized trial comparing CYA and MTX with CYA and mycophenolate mofetil for GVHD prophylaxis in myeloablative sibling donor hematopoietic cell transplantation

Risk factors for vancomycin-resistant enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation

Does day 11 omission of methotrexate due to toxicity influence the outcome in myeloablative hematopoietic cell transplant? Results from a single-center retrospective cohort study

Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation

High prevalence of diarrhea but infrequency of documented Clostridium difficile in autologous peripheral blood progenitor cell transplant recipients

Etoposide (VP-16) plus G-CSF mobilizes different dendritic cell subsets than does G-CSF alone

Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection

BU- vs TBI-based conditioning for adult patients with ALL

CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens

Prognostic importance of the axillary lymph node ratio in autologous transplantation for high-risk stage II/III breast cancer

Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course

A randomized study of multi-day infusion of autologous peripheral blood progenitor cells

Comparison of donor chimerism following myeloablative and nonmyeloablative allogeneic hematopoietic SCT

Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia

Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant

Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation

Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation

Autologous hematopoietic cell transplantation for non-Hodgkin's lymphoma: 100 month follow-up

Syngeneic hematopoietic stem cell transplantation for women with metastatic breast cancer

Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group

Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study

Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?

Intravenous compared with oral busulfan as preparation for allogeneic hematopoietic progenitor cell transplantation for AML and MDS

Phase 1 study of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in breast cancer patients after autologous peripheral blood progenitor cell (PBPC) transplantation

Durability of remission after ABMT for NHL: the importance of the 2-year evaluation point

G-CSF post-autologous progenitor cell transplantation: a randomized study of 5, 10, and 16 μ g/kg/day

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

Utility of the psychosocial assessment of candidates for transplantation (PACT) scale in allogeneic BMT

LDH elevation after autologous stem cell transplantation

A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma

Quick links

Refine your results by…

Filters ​

Filter By:

Search

Quick links

Filters